Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
Danish health authorities said Thursday they were temporarily suspending the use of AstraZeneca’s Covid-19 vaccine after some patients developed blood clots because receiving the jab.
The move comes”following reports of serious cases of blood clots among individuals vaccinated with AstraZeneca’s Covid-19 vaccine”, the Danish Health Authority said in a statement.
But it carefully added that”it hasn’t yet been determined, in the time being, that there’s a connection between the vaccine and the blood clots”.
Austria declared on Monday that it had suspended the use of a batch of AstraZeneca vaccines following a 49-year-old nurse died of”severe blood coagulation problems” days after having an anti-Covid shot.
Four other European countries — Estonia, Latvia, Lithuania and Luxemburg — have also suspended the use of vaccines from this batch, which was sent to 17 European countries and consisting of one million jabs.
Denmark has however suspended the use of all its AstraZeneca supply.
On Wednesday, Europe’s medicines watchdog EMA said a preliminary probe revealed that the batch of AstraZeneca vaccines used in Austria was likely not to blame for the nurse’s death.
As of March 9, 22 cases of blood clots had been reported among more than three million people vaccinated in the European Economic Area, the EMA said.
“It is important to point out that we have not terminated using the AstraZeneca vaccine, we’re just pausing its usage,” Danish Health Authority director Soren Brostrom said in the announcement.
Denmark said one person had died after receiving the vaccine.
“There’s broad documentation demonstrating that the vaccine is both safe and efficient. But both we and the Danish Medicines Agency must act on information about potential serious side effects, both in Denmark and in other European countries,” Brostrom said.
The suspension, which is assessed after two weeks, is expected to slow down Denmark’s vaccination campaign.
Copenhagen now hopes to have its entire adult population vaccinated by mid-August rather than early July, the health authority said.
